{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:28:11Z","timestamp":1791224891227,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":612,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,31]]},"DOI":"10.1093\/nar\/gkv163","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:13:27Z","timestamp":1425946407000},"page":"3318-3331","source":"Crossref","is-referenced-by-count":92,"title":["Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy"],"prefix":"10.1093","volume":"43","author":[{"given":"Agnieszka","family":"Wojtkowiak-Szlachcic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Stepniak-Konieczna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz J.","family":"Sznajder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Mykowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Sroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Sobczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,9]]},"reference":[{"key":"key\n\t\t\t\t20171011202546_B1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-08-045031-5.00015-3","article-title":"Myotonic dystrophy types 1 and 2","volume":"101","author":"Ashizawa","year":"2011","journal-title":"Handb. Clin. Neurol."},{"key":"key\n\t\t\t\t20171011202546_B2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(92)90154-5","article-title":"Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member","volume":"68","author":"Brook","year":"1992","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171011202546_B3","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1073\/pnas.94.14.7388","article-title":"Expansion of a CUG trinucleotide repeat in the 3\u2032 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts","volume":"94","author":"Davis","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20171011202546_B4","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","article-title":"Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy","volume":"19","author":"Miller","year":"2000","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20171011202546_B5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cell.2012.06.041","article-title":"Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins","volume":"150","author":"Wang","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171011202546_B6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molcel.2007.07.027","article-title":"Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation","volume":"28","author":"Kuyumcu-Martinez","year":"2007","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20171011202546_B7","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/hmg\/ddl132","article-title":"Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy","volume":"15","author":"Lin","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171011202546_B8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molcel.2007.01.031","article-title":"Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets","volume":"25","author":"Krol","year":"2007","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20171011202546_B9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/mt.2012.222","article-title":"RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy","volume":"21","author":"Sobczak","year":"2013","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20171011202546_B10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1525-0016(03)00068-6","article-title":"Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts","volume":"7","author":"Langlois","year":"2003","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20171011202546_B11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nsmb.1958","article-title":"Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs","volume":"18","author":"Francois","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20171011202546_B12","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/mt.2011.191","article-title":"Stabilization of expanded (CTG)*(CAG) repeats by antisense oligonucleotides","volume":"19","author":"Nakamori","year":"2011","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20171011202546_B13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in vivo correction of myotonic dystrophy","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171011202546_B14","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1073\/pnas.1117019109","article-title":"RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20171011202546_B15","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.0905780106","article-title":"Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy","volume":"106","author":"Mulders","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20171011202546_B16","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1038\/mtna.2013.9","article-title":"Design and analysis of effects of triplet repeat oligonucleotides in cell models for myotonic dystrophy","volume":"2","author":"Gonzalez-Barriga","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"key\n\t\t\t\t20171011202546_B17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.1173110","article-title":"Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA","volume":"325","author":"Wheeler","year":"2009","journal-title":"Science"},{"key":"key\n\t\t\t\t20171011202546_B18","doi-asserted-by":"crossref","first-page":"10873","DOI":"10.1093\/nar\/gku767","article-title":"MBNL proteins and their target RNAs, interaction and splicing regulation","volume":"42","author":"Konieczny","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011202546_B19","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1021\/cr050266u","article-title":"Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA)","volume":"107","author":"Kaur","year":"2007","journal-title":"Chem. Rev."},{"key":"key\n\t\t\t\t20171011202546_B20","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.2174\/0929867311320290004","article-title":"Canonical and non-canonical barriers facing antimiR cancer therapeutics","volume":"20","author":"Cheng","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"key\n\t\t\t\t20171011202546_B21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/1545457041526317","article-title":"Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology","volume":"14","author":"Jepsen","year":"2004","journal-title":"Oligonucleotides"},{"key":"key\n\t\t\t\t20171011202546_B22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-1221-6_9","article-title":"Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects","volume":"825","author":"Rigo","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"key\n\t\t\t\t20171011202546_B23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","article-title":"RNA-based therapeutics: current progress and future prospects","volume":"19","author":"Burnett","year":"2012","journal-title":"Chem. Biol."},{"key":"key\n\t\t\t\t20171011202546_B24","first-page":"189","article-title":"The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence","volume":"487","author":"Fluiter","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20171011202546_B25","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1158\/1535-7163.MCT-08-0510","article-title":"A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth","volume":"7","author":"Greenberger","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20171011202546_B26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20171011202546_B27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/nat.2011.0332","article-title":"A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys","volume":"22","author":"Hildebrandt-Eriksen","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t20171011202546_B28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.786","article-title":"Silencing of microRNA families by seed-targeting tiny LNAs","volume":"43","author":"Obad","year":"2011","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20171011202546_B29","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1073\/pnas.94.14.7394","article-title":"Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes","volume":"94","author":"Hamshere","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20171011202546_B30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0793-233","article-title":"Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene","volume":"4","author":"Sabouri","year":"1993","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20171011202546_B31","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1093\/nar\/gkq1323","article-title":"Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference","volume":"39","author":"de\u00a0Mezer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011202546_B32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4161\/rna.28799","article-title":"Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1","volume":"11","author":"Wojciechowska","year":"2014","journal-title":"RNA Biol."},{"key":"key\n\t\t\t\t20171011202546_B33","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t20171011202546_B34","first-page":"3952","article-title":"Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy","volume":"117","author":"Wheeler","year":"2007","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20171011202546_B35"},{"key":"key\n\t\t\t\t20171011202546_B36","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1093\/nar\/gkr608","article-title":"CAG repeats mimic CUG repeats in the misregulation of alternative splicing","volume":"39","author":"Mykowska","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011202546_B37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nsmb.1720","article-title":"Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy","volume":"17","author":"Du","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20171011202546_B38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng704","article-title":"Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy","volume":"29","author":"Savkur","year":"2001","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20171011202546_B39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ana.23992","article-title":"Splicing biomarkers of disease severity in myotonic dystrophy","volume":"74","author":"Nakamori","year":"2013","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20171011202546_B40","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1038\/ncomms3044","article-title":"Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules","volume":"4","author":"Childs-Disney","year":"2013","journal-title":"Nat. Commun."},{"key":"key\n\t\t\t\t20171011202546_B41","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1101\/gad.191338.112","article-title":"Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain","volume":"26","author":"Licatalosi","year":"2012","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20171011202546_B42","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature07488","article-title":"HITS-CLIP yields genome-wide insights into brain alternative RNA processing","volume":"456","author":"Licatalosi","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171011202546_B43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nsmb.1545","article-title":"An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells","volume":"16","author":"Yeo","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"key\n\t\t\t\t20171011202546_B44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.280.5364.737","article-title":"Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy","volume":"280","author":"Philips","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t20171011202546_B45","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkp841","article-title":"Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents","volume":"38","author":"Stein","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011202546_B46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/emmm.201100171","article-title":"Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice","volume":"3","author":"Garchow","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"key\n\t\t\t\t20171011202546_B47","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1158\/0008-5472.CAN-13-0927","article-title":"Silencing of the miR-17\u223c92 cluster family inhibits medulloblastoma progression","volume":"73","author":"Murphy","year":"2013","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20171011202546_B48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","article-title":"Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy","volume":"10","author":"Mankodi","year":"2002","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20171011202546_B49","first-page":"4-1-22","article-title":"A status update of modified oligonucleotides for chemotherapeutics applications","author":"Sanghvi","year":"2011","journal-title":"Curr. Protoc. Nucleic Acid Chem."},{"key":"key\n\t\t\t\t20171011202546_B50","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","article-title":"Potent and nontoxic antisense oligonucleotides containing locked nucleic acids","volume":"97","author":"Wahlestedt","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20171011202546_B51","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/mp900093r","article-title":"Biological barriers to therapy with antisense and siRNA oligonucleotides","volume":"6","author":"Juliano","year":"2009","journal-title":"Mol. Pharm."},{"key":"key\n\t\t\t\t20171011202546_B52","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1093\/nar\/gkr089","article-title":"Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes","volume":"39","author":"Koller","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20171011202546_B53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/hum.2012.234","article-title":"Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy","volume":"24","author":"Koo","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"key\n\t\t\t\t20171011202546_B54","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20171011202546_B55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2012.0404","article-title":"Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy","volume":"23","author":"Leger","year":"2013","journal-title":"Nucleic Acid Ther."},{"key":"key\n\t\t\t\t20171011202546_B56","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/srep02242","article-title":"Ultrasound-enhanced delivery of morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice","volume":"3","author":"Koebis","year":"2013","journal-title":"Sci. Rep."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/43\/6\/3318\/17434924\/gkv163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:22:52Z","timestamp":1566418972000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/nar\/article\/43\/6\/3318\/2453443\/Short-antisenselocked-nucleic-acids-allLNAs"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,9]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,3,9]]},"published-print":{"date-parts":[[2015,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkv163","relation":{},"ISSN":["1362-4962","0305-1048"],"issn-type":[{"value":"1362-4962","type":"electronic"},{"value":"0305-1048","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,3,31]]},"published":{"date-parts":[[2015,3,9]]}}}